Acknowledgments

transfusion-associated cases were re-ported throughout the year, underscor-ing the need for constant awareness. The 2 cases of probable congenital in-fection highlight the need to consider Babesia infection for newborns who have compatible clinical manifesta-tions, especially if the mother had risk factors for infection. Prompt identification of babesio-sis is essential to prevent disease trans-mission from infected blood donors to recipients. Although we modified New Jersey surveillance to include transfu-sion as a risk factor, collaboration with stakeholders (including blood centers) will further facilitate case detection and confirmation and identification of infected donors. Including babesiosis on the list of nationally notifiable dis-eases will improve national disease re-porting and clarify the geographic dis-tribution and incidence of tickborne and possible transfusion-associated cases. With increasing public aware-ness and screening, public health professionals and stakeholders might consider dedicating public health re-sources for babesiosis surveillance